How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/neonatal-group-b-streptococcal-septicemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Neonatal Group B Streptococcal Septicemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neonatal Group B Streptococcal Septicemia (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Neonatal Group B Streptococcal Septicemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Claforan	CEFOTAXIME	Sterimax	Cephalosporin Antibacterial		1981-01-01
Unasyn	AMPICILLIN	Bristol-Myers Squibb	Penicillin-class Antibacterial	Transient receptor potential cation channel subfamily M member 4	1965-01-01
Penicillin G Potassium In Plastic Container	Benzylpenicillin	Pfizer	Penicillin-class Antibacterial		1947-01-01
Vancocin	vancomycin	ANI Pharmaceuticals		Alpha-2A adrenergic receptor, D-alanyl-D-alanine dipeptidase, UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
penicillin	penicillin	Karlstad University		Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

ANI Pharmaceuticals · 1 drug in Neonatal Group B Streptococcal Septicemia
Bristol-Myers Squibb · 1 drug in Neonatal Group B Streptococcal Septicemia
Karlstad University · 1 drug in Neonatal Group B Streptococcal Septicemia
Pfizer · 1 drug in Neonatal Group B Streptococcal Septicemia
Sterimax · 1 drug in Neonatal Group B Streptococcal Septicemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Neonatal Group B Streptococcal Septicemia:

Cite this brief

Drug Landscape (2026). Neonatal Group B Streptococcal Septicemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/neonatal-group-b-streptococcal-septicemia. Accessed 2026-06-10.

Neonatal Group B Streptococcal Septicemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing